New monthly shot aims to keep schizophrenia symptoms at bay

NCT ID NCT06961968

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a long-acting injection of iloperidone can delay or prevent the return of schizophrenia symptoms compared to a placebo injection. About 400 adults with schizophrenia who need ongoing treatment will receive either the drug or a placebo and be monitored for how long it takes for symptoms to worsen. The goal is to see if this monthly shot helps people stay stable longer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Vanda Investigational Site

    RECRUITING

    Rogers, Arkansas, 72758, United States

  • Vanda Investigational Site

    RECRUITING

    Costa Mesa, California, 92626, United States

  • Vanda Investigational Site

    RECRUITING

    Lemon Grove, California, 91945, United States

  • Vanda Investigational Site

    RECRUITING

    Oceanside, California, 92056, United States

  • Vanda Investigational Site

    RECRUITING

    Pico Rivera, California, 90660, United States

  • Vanda Investigational Site

    RECRUITING

    San Diego, California, 92123, United States

  • Vanda Investigational Site

    RECRUITING

    Walnut Creek, California, 94596, United States

  • Vanda Investigational Site

    RECRUITING

    North Miami, Florida, 33161, United States

  • Vanda Investigational Site

    RECRUITING

    Atlanta, Georgia, 30328, United States

  • Vanda Investigational Site

    RECRUITING

    Peachtree Corners, Georgia, 30071, United States

  • Vanda Investigational Site

    RECRUITING

    Chicago, Illinois, 60641, United States

  • Vanda Investigational Site

    RECRUITING

    Flowood, Mississippi, 39232, United States

  • Vanda Investigational Site

    RECRUITING

    Saint Charles, Missouri, 63304, United States

  • Vanda Investigational Site

    RECRUITING

    St Louis, Missouri, 63141, United States

  • Vanda Investigational Site

    RECRUITING

    Las Vegas, Nevada, 89119, United States

  • Vanda Investigational Site

    RECRUITING

    Marlton, New Jersey, 08053, United States

  • Vanda Investigational Site

    RECRUITING

    Staten Island, New York, 10314, United States

  • Vanda Investigational Site

    RECRUITING

    Austin, Texas, 78754, United States

  • Vanda Investigational Site

    RECRUITING

    Houston, Texas, 77081, United States

  • Vanda Investigational Site

    RECRUITING

    Irving, Texas, 75062, United States

  • Vanda Investigational Site

    RECRUITING

    Richardson, Texas, 75080, United States

  • Vanda Investigational Site

    RECRUITING

    Bellevue, Washington, 98007, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.